David Reardon on Caring for Patients With Glioblastoma
David Reardon, MD, clinical director, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses caring for patients with glioblastoma.
David Reardon, MD, clinical director, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses caring for patients with glioblastoma.
Most patients do not present with many symptoms prior to diagnosis, Reardon says, but the disease develops acutely and aggressively. In addition to negative effects from the disease and its treatment, a diagnosis may lead to problems with family, work, or the ability to accomplish daily tasks.
Reardon says that caregivers play an important role in caring for these patients, and a team approach should be utilized, including nursing staff, clinical staff, and social work support.
FDA Approves Eflornithine for Children, Adults With High-Risk Neuroblastoma
December 14th 2023Eflornithine (Iwilfin) received FDA approval to reduce the risk for relapse in pediatric and adult patients with high-risk neuroblastoma, making it the first therapy to reduce risk for relapse in children with the disease.
